Name

Alitretinoin

Alternate Names

None

Abbreviations

9cRA

Category

Differentiation inducing agent

Subcategory

None

NSC Number

659772

Primary Site

Breast
Kaposi sarcoma
leukemia
sarcoma
skin cancer

Histology

None

Remarks

Phase II (breast, sarcoma, skin) Phase III APL A natural retinoid with actions similar to all-trans-retinoic acid (tretinoin). FDA approved use for Kaposi's sarcoma. Ligand Pharamceuticals, Vical, NCI.

Coding

This drug should NOT be coded
Glossary